Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WA › Seattle › NPI 1356496582
Hospital

Swedish Health Services

Swedish Health Services was paid $20.06M by Medicaid between Jan 2018 and Dec 2024, across 272 billing codes. Its largest line is 96361, Intravenous infusion, hydration; each additional hour — 12% of everything it billed.

33Billing provider infoSWEDISH HEALTH SERVICES
SEATTLE, WA 98124
33aNPI1356496582assigned 01/25/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$20.06M
24GClaims614,050
24DCodes billed272
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Washington

Rank by total paid#25 of 49
Median peer was paid$20.06M
This provider vs. median1.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201897,840$3.13M
201998,584$3.15M
202078,515$2.55M
202199,715$3.18M
202290,320$2.86M
202380,365$2.71M
2024incomplete68,711$2.47M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
96361 Intravenous infusion, hydration; each additional hour 12% 8,784 7,873 $2.44M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 7.4% 14,295 13,301 $1.49M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 6.7% 18,060 16,797 $1.35M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 6.0% 15,170 14,209 $1.21M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 5.2% 6,116 5,971 $1.04M
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 5.0% 4,833 4,696 $1.00M
95810 Polysomnography; sleep staging with 4 or more additional parameters 4.4% 1,773 1,741 $874K
29581 3.5% 4,644 1,943 $694K
70450 Computed tomography, head or brain; without contrast material 3.2% 5,460 5,166 $634K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 2.4% 1,933 1,855 $490K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.4% 3,079 2,954 $477K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 1.9% 7,542 5,373 $377K
260 more codes
70551 Magnetic resonance imaging, brain; without contrast material 1.8% 2,314 $355K
71275 Computed tomographic angiography, chest, with contrast material 1.6% 2,237 $313K
76705 Ultrasound, abdominal, real time with image documentation; limited 1.5% 4,118 $304K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1.4% 1,316 $276K
93017 1.4% 4,073 $275K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 1.4% 3,820 $274K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.3% 12,320 $265K
95811 1.2% 557 $241K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.2% 2,832 $237K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.2% 2,799 $237K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.2% 6,823 $234K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.1% 2,662 $230K
76830 Ultrasound, transvaginal 1.1% 2,665 $225K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 7,974 $194K
93350 <1% 945 $164K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 2,839 $159K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 962 $139K
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography <1% 761 $139K
93325 <1% 1,754 $138K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 1,998 $131K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 1,205 $129K
70496 <1% 1,762 $125K
70498 <1% 1,530 $124K
76801 <1% 1,844 $119K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 2,858 $117K
93458 <1% 142 $114K
97597 <1% 2,274 $114K
71046 Radiologic examination, chest; 2 views <1% 7,291 $111K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 5,274 $109K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 5,944 $105K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 1,375 $99K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 1,092 $96K
76536 <1% 1,227 $96K
95819 <1% 633 $92K
80053 Comprehensive metabolic panel <1% 19,697 $90K
97162 <1% 2,172 $82K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 1,169 $81K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 459 $73K
72141 <1% 709 $72K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 3,739 $65K
84484 <1% 16,774 $61K
97535 Self-care/home management training, each 15 minutes <1% 3,244 $58K
72110 <1% 2,309 $58K
93970 <1% 652 $53K
95813 <1% 120 $46K
77373 <1% 158 $45K
73562 <1% 1,573 $42K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 20,505 $42K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 1,085 $41K
93321 <1% 543 $41K
72050 <1% 1,382 $40K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 442 $39K
72156 <1% 553 $35K
80048 Basic metabolic panel (calcium, ionized) <1% 8,497 $31K
G0378 Hospital observation service, per hour <1% 3,556 $28K
83605 <1% 6,260 $27K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 522 $27K
80047 <1% 7,131 $27K
73030 <1% 1,701 $26K
93880 <1% 640 $26K
J0475 Injection, baclofen, 10 mg <1% 136 $24K
73630 <1% 1,569 $23K
72100 <1% 1,620 $23K
97161 <1% 620 $22K
77470 <1% 37 $22K
73610 <1% 1,307 $20K
73130 <1% 1,159 $20K
83880 <1% 4,619 $20K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,930 $19K
72125 Computed tomography, cervical spine; without contrast material <1% 876 $19K
84145 <1% 2,475 $18K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 27,942 $16K
71045 Radiologic examination, chest; single view <1% 9,556 $16K
97163 <1% 450 $15K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 4,067 $15K
71250 <1% 330 $15K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,097 $14K
87040 <1% 2,288 $13K
80076 <1% 4,243 $13K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 11,802 $13K
73502 <1% 847 $12K
72082 <1% 438 $11K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 912 $10K
73110 <1% 648 $10K
85379 <1% 1,799 $8K
93978 <1% 284 $8K
93971 <1% 81 $7K
72040 <1% 387 $7K
76377 <1% 2,948 $7K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 408 $6K
62370 <1% 121 $6K
96375 Therapeutic injection; each additional sequential IV push <1% 8,324 $6K
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 677 $6K
10060 <1% 26 $6K
75561 <1% 27 $6K
73564 <1% 721 $5K
97166 <1% 195 $5K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 36 $5K
84443 Thyroid stimulating hormone (TSH) <1% 1,900 $5K
84703 <1% 6,382 $5K
77334 <1% 89 $5K
76770 <1% 51 $4K
77295 <1% 15 $4K
97165 <1% 111 $4K
C1769 Guide wire <1% 2,181 $4K
85027 <1% 4,592 $4K
36415 Collection of venous blood by venipuncture <1% 6,509 $4K
77290 <1% 41 $4K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 362 $3K
93225 <1% 132 $3K
85610 <1% 9,520 $3K
J2060 Injection, lorazepam, 2 mg <1% 2,462 $3K
82075 <1% 635 $3K
80305 <1% 2,278 $3K
83690 <1% 8,855 $3K
75574 <1% 16 $3K
72158 <1% 24 $3K
72157 <1% 61 $2K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 10,894 $2K
70544 <1% 29 $2K
82962 <1% 8,480 $2K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 431 $2K
87486 <1% 423 $2K
87581 <1% 423 $2K
83735 <1% 3,258 $2K
97116 <1% 204 $2K
72131 <1% 36 $2K
90715 <1% 106 $2K
74174 <1% 58 $2K
83036 Hemoglobin; glycosylated (A1C) <1% 856 $2K
87081 <1% 651 $2K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 66 $2K
82553 <1% 349 $2K
82565 <1% 3,130 $2K
J1756 Injection, iron sucrose, 1 mg <1% 27 $2K
85730 <1% 3,352 $1K
93798 <1% 184 $1K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 7,297 $1K
86850 <1% 1,053 $1K
87631 <1% 94 $1K
73560 <1% 39 $1K
82803 <1% 3,108 $1K
96376 <1% 2,704 $1K
76882 <1% 12 $1K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 4,016 $1K
81003 <1% 5,767 $1K
A9585 Injection, gadobutrol, 0.1 ml <1% 6,345 $1K
99152 <1% 1,471 $1K
86900 <1% 1,741 $1K
93312 <1% 16 $1K
86901 <1% 1,849 $1K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 1,652 $987.86
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 3,333 $941.20
J3010 Injection, fentanyl citrate, 0.1 mg <1% 4,232 $931.92
77336 <1% 28 $923.86
76937 <1% 12 $895.98
82728 <1% 247 $865.81
99153 Mod sedat endo service >5yrs <1% 984 $860.88
J1170 Injection, hydromorphone, up to 4 mg <1% 3,021 $808.12
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 898 $794.43
81001 <1% 5,524 $792.44
87158 <1% 86 $763.32
J7030 Infusion, normal saline solution , 1000 cc <1% 3,148 $728.54
87086 Culture, bacterial; quantitative colony count, urine <1% 1,748 $669.10
72070 <1% 37 $642.79
94729 <1% 36 $630.14
86140 <1% 1,979 $589.91
77300 <1% 15 $578.80
94060 <1% 12 $573.34
70486 <1% 24 $569.68
77280 <1% 15 $568.33
76820 <1% 13 $560.31
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 1,270 $475.00
80061 Lipid panel <1% 127 $467.74
97760 <1% 17 $464.92
73140 <1% 27 $455.20
76813 <1% 13 $452.16
J1644 Injection, heparin sodium, per 1000 units <1% 3,254 $429.69
J2785 Injection, regadenoson, 0.1 mg <1% 1,907 $396.49
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,694 $390.51
84702 <1% 755 $373.61
77370 <1% 15 $358.07
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,634 $357.98
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 5,248 $334.48
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 225 $324.64
73080 <1% 12 $316.58
85014 <1% 555 $309.98
82550 <1% 801 $308.58
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 3,091 $300.31
83540 <1% 233 $277.34
J3490 Unclassified drugs <1% 715 $276.30
C1760 Closure device, vascular (implantable/insertable) <1% 60 $263.56
J2704 Injection, propofol, 10 mg <1% 1,897 $237.46
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 910 $225.88
93922 <1% 15 $219.18
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,943 $208.19
85651 <1% 1,160 $207.40
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,177 $197.73
A9270 Non-covered item or service <1% 6,770 $192.88
83550 <1% 154 $184.04
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,613 $176.99
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) <1% 422 $171.28
87186 <1% 449 $166.34
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 916 $142.57
Q9957 Injection, perflutren lipid microspheres, per ml <1% 1,409 $114.86
73590 <1% 13 $111.93
74018 <1% 26 $111.20
36000 <1% 441 $92.69
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,896 $84.64
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 1,134 $82.56
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 579 $79.91
87210 <1% 155 $75.71
85347 <1% 468 $75.64
J1650 Injection, enoxaparin sodium, 10 mg <1% 668 $75.08
82150 <1% 947 $72.98
87070 <1% 206 $69.56
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 153 $68.76
85670 <1% 96 $64.80
93925 <1% 12 $50.63
87205 <1% 209 $43.36
J0690 Injection, cefazolin sodium, 500 mg <1% 1,605 $41.97
85049 <1% 60 $39.29
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 832 $28.03
85384 <1% 43 $18.87
81025 <1% 508 $18.59
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 614 $10.02
87430 <1% 90 $9.50
J1815 Injection, insulin, per 5 units <1% 905 $8.72
J1171 Injection, hydromorphone, 0.1 mg <1% 43 $8.27
84100 <1% 79 $7.50
J3370 Injection, vancomycin hcl, 500 mg <1% 786 $6.90
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 665 $6.09
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 29 $5.68
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 187 $4.36
J3475 Injection, magnesium sulfate, per 500 mg <1% 74 $4.09
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 99 $3.89
84132 <1% 15 $3.73
J7050 Infusion, normal saline solution, 250 cc <1% 783 $2.92
C9113 Injection, pantoprazole sodium, per vial <1% 218 $0.62
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 395 $0.00
80179 0% 72 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 0% 165 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 16,934 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 434 $0.00
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 0% 27 $0.00
G8989 Self care functional limitation, discharge status, at discharge from therapy or to end reporting 0% 14 $0.00
J2359 Injection, olanzapine, 0.5 mg 0% 21 $0.00
93356 0% 12 $0.00
76376 0% 14 $0.00
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose 0% 346 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 0% 582 $0.00
J1940 Injection, furosemide, up to 20 mg 0% 118 $0.00
G8987 Self care functional limitation, current status, at therapy episode outset and at reporting intervals 0% 59 $0.00
J0360 Injection, hydralazine hcl, up to 20 mg 0% 15 $0.00
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) 0% 14 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 0% 119 $0.00
G8988 Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 61 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 0% 114 $0.00
94761 0% 143 $0.00
J1630 Injection, haloperidol, up to 5 mg 0% 33 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialANDERSON, DONALD (ASSISTANT SECREATRY FOR ENROLLMENT)
Same official

Other billing entities under ANDERSON, DONALD

Full network →
ProviderLocationPaid
Providence Health & Services WashingtonAnchorage, AK$161.45M
Kadlec Regional Medical CenterRichland, WA$151.60M
Swedish EdmondsEdmonds, WA$30.06M
ST. Joseph Health Northern California, LLCEureka, CA$28.68M
Providence Health System Southern CaliforniaTorrance, CA$27.29M
Providence Health System - Southern CaliforniaSan Pedro, CA$24.26M
Providence Health & Services - WashingtonTukwila, WA$21.98M
Swedish Health ServicesSeattle, WA$21.06M
Providence Health & Services WashingtonKodiak, AK$11.39M
Swedish Health ServicesSeattle, WA$11.08M
ST. Joseph Health Northern California, LLCFortuna, CA$8.55M
Collabria CareNapa, CA$8.20M
Providence Health & Services OregonSeaside, OR$8.01M
Providence Health & Services- WashingtonSpokane, WA$8.01M
Hospice of Lubbock INCLubbock, TX$6.48M
Providence Saint John's Health CenterSanta Monica, CA$5.52M
Methodist Hospital LevellandLevelland, TX$4.55M
Collabria CareNapa, CA$4.05M
Methodist Hospital LevellandLevelland, TX$4.01M
Methodist Hospital Plainview TexasPlainview, TX$4.00M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.